StockWatch
·

DMCC Speciality Chemicals Ltd

BSE: 506405

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
273.05
+7.8%+116.2%
Expenditure
269.09
+19.0%+128.0%
Net Profit
3.21
-84.3%-44.2%
OPM %
4.17%
-9.32pp-6.94pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0076.45152.91229.36305.82Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

DMCC Q2 FY27: Revenue surges 116% YoY but consolidated PAT falls 44% as margins collapse

specialty chemicals · margin compression · inventory gains reversal

ResultsQ2 FY2730 Oct 20263 minMetals & Mining

Sulphur up 231% YoY in GSFC's Q1 filing; the biggest results-day gain went to the company that sells it

sulphur · fertilisers · Q1 FY27 results

Research24 Sept 20266 minMetals & Mining

DMCC Q1 FY27: consolidated revenue nearly doubles YoY, PAT surges 163% to ₹20.4 Cr

speciality chemicals · revenue growth · margin expansion

ResultsQ1 FY2710 Aug 20263 minMetals & Mining
Latest
Board Meeting30 Oct, 3:08 pm

DMCC Q2 FY27: Revenue surges 116% YoY but consolidated PAT falls 44% as margins collapse

DMCC's consolidated revenue continued to compound, up 116.5% YoY to ₹272.88 Cr (+7.9% QoQ from ₹253.01 Cr), but consolidated PAT fell 43.9% YoY to ₹3.23 Cr and collapsed 84.2% QoQ from ₹20.40 Cr — EPS ₹1.29 versus ₹2.31 a year ago and ₹8.18 last quarter. The profitability reversal was flagged by management itself: at the Q1 FY27 print the company explicitly warned that "a meaningful portion of the reported profitability reflects inventory gains... these gains will reverse as prices moderate, and profits will normalise" — this quarter's print satisfies that warning almost to the letter, so against management's own prior guidance the result is a clean 'met', not a surprise. No formal Street consensus for Q2 FY27 specifically surfaced in available coverage; the closest market reference is a ~15-20% full-year FY27 PAT growth assumption underlying recent analyst price targets, a bar H1 FY27's ₹23.63 Cr consolidated PAT (+75% YoY) still clears on a half-year basis even after this quarter's reversal. The compression sits squarely in the raw-material line: consumption of raw materials rose to 86.4% of revenue this quarter, up from 78.1% in Q1 FY27 and 67.9% a year ago, pulling operating margin down to 1.46% from 13.49% QoQ and net margin to 1.18% from 8.06% QoQ / 4.55% YoY. Total expenses grew faster than income quarter-on-quarter, and finance costs also rose to ₹3.83 Cr from ₹1.91 Cr YoY on higher short-term borrowings (₹66.52 Cr versus ₹49.62 Cr at FY26-end), adding a secondary drag below the operating line. Standalone and consolidated are near-identical this quarter (PAT ₹3.21 Cr standalone versus ₹3.23 Cr consolidated) — the German subsidiary remains immaterial. The continued revenue doubling is consistent with the cautiously optimistic "FY27 better than FY25-26" framing management gave on the Q4 FY26 call, including early commercial traction in boron derivatives, but that call's qualitative outlook said nothing about the margin trajectory now playing out. Separately, BSE sought and received a clarification from the company on October 7, 2026 over unusual trading-volume/price movement in the stock; management attributed it to market conditions, unrelated to this quarter's operating numbers. No management press release accompanying this specific result was available to cross-check framing beyond the regulatory filing itself.

30 Oct 2026, 03:08 pm

Corporate Events

Board MeetingDMCC
2026
30Oct

Board Meeting

The Board of Directors meeting is scheduled to consider, app…

BSE Filing ↗
Board MeetingDMCC
2026
11Sep

Board Meeting

The 105th Annual General Meeting (AGM) will be held to recei…

BSE Filing ↗
DividendDMCC
2026
21Aug

₹2.5 / share

BSE Filing ↗
Board MeetingDMCC
2026
10Aug

Board Meeting

The Board of Directors meeting is scheduled to consider, app…

BSE Filing ↗
Board MeetingDMCC
2026
15May

Board Meeting

The Board Meeting was held on May 15, 2026, to recommend a d…

BSE Filing ↗
Board MeetingDMCC
2025
11Nov

Board Meeting

consider, approve and take on record the Unaudited (Standalo…

BSE Filing ↗
DividendDMCC
2025
22Aug

₹2.5 / share

BSE Filing ↗
Board MeetingDMCC
2025
7Aug

Board Meeting

Consider, approve and take on record the Unaudited (Standalo…

BSE Filing ↗
Board MeetingDMCC
2025
12Feb

Board Meeting

consider, approve and take on record the Unaudited (Standalo…

BSE Filing ↗
Board MeetingDMCC
2024
28Oct

Board Meeting

consider and approve and take on record Unaudited (Standalon…

BSE Filing ↗
Board MeetingDMCC
2024
23May

Board Meeting

Consider and approve (Audited Financial Results, Recommendat…

BSE Filing ↗
Board MeetingDMCC
2024
9Feb

Board Meeting

Consider and approve the Unaudited Standalone & Consolidated…

BSE Filing ↗
Board MeetingDMCC
2023
8Nov

Board Meeting

Consider and approve the Unaudited (Standalone & Consolidate…

BSE Filing ↗
Board MeetingDMCC
2023
9Aug

Board Meeting

Consider and approve Unaudited (Standalone & Consolidated) F…

BSE Filing ↗